A time course study showed that treatment with BETd-260 for 1 h largely reduced the level of BRD2, BRD3, and BRD4 proteins and for 12 h completely eliminated the BET proteins in the HCC cells (Figure 1B). This evidence concerns the gene DNER and hepatocellular carcinoma.